Compare Opendoor Technologies Inc (OPEN) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Opendoor Technologies Inc vs BIO-TECHNE Corp — how do they compare? Opendoor Technologies Inc trades at $4.38 (market cap $4.32B), while BIO-TECHNE Corp trades at $71.73 (market cap $11.16B). The key difference: BIO-TECHNE Corp is far larger — about 2.6× Opendoor Technologies Inc's market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Opendoor Technologies Inc pays none. Which is the better fit depends on your goals.
| OPEN | TECH | |
|---|---|---|
Market Cap | $4.32B | $11.16B |
Sector | Real Estate | Health |
52-Week High | $10.52 | $72.12 |
52-Week Low | $1.84 | $43.31 |
Enterprise Value | $4.66B | $11.24B |
Dividend Yield | — | 0.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Opendoor Technologies (OPEN) trades at $4.48, down 0.44% on the day, with a bearish technical outlook and mixed fundamental signals. The stock shows a low price-to-sales ratio of 0.93 but suffers from significant losses, with a net income margin of -35.25% and negative ROE of -173.61%. Recent earnings have been volatile, missing estimates in Q1 2026. Cash flow improved in 2025 with net cash flow of $538 million, though revenue declined to $4.37 billion. News highlights include the upcoming Q2 2026 earnings report and strategic shifts like closing India operations to focus on AI.
The outlook remains challenging due to persistent losses and a tough housing market, but cost-cutting and operational adjustments under new CEO Kaz Nejatian offer potential for margin improvement. Risks include high debt, competitive pressure from Zillow, and interest rate sensitivity. Analyst sentiment is cautious with 65.39% hold ratings, reflecting uncertainty about sustainable profitability. Investors should weigh the low valuation against execution risks in a volatile sector.
Bio-Techne (TECH) trades at $71.63, down 0.68% on the day, near its all-time high following a $73 per share acquisition offer from Merck KGaA. The stock shows bullish technical signals with strong moving averages and ADX trends. Fundamentally, the company reported mixed quarterly earnings but maintains solid gross margins of 64.96%. Recent news is dominated by the proposed $11.3 billion buyout, driving significant investor interest and legal scrutiny over the transaction's fairness.
The outlook is heavily influenced by the pending acquisition, with upside capped near the $73 offer price. Risks include shareholder litigation and regulatory approval delays. Analyst consensus is split evenly between Buy and Hold, reflecting uncertainty around deal completion. The stock presents a potential arbitrage opportunity if the acquisition proceeds, but carries event risk if the transaction fails.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Opendoor Technologies Inc
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
